- Home
- PBYI vs BRKH Comparison
PBYI vs BRKH Comparison
Compare PBYI & BRKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BRKH
- Stock Information
- Founded
- PBYI 2010
- BRKH 2021
- Country
- PBYI United States
- BRKH United States
- Employees
- PBYI N/A
- BRKH N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BRKH Blank Checks
- Sector
- PBYI Health Care
- BRKH Finance
- Exchange
- PBYI Nasdaq
- BRKH Nasdaq
- Market Cap
- PBYI 176.1M
- BRKH 170.5M
- IPO Year
- PBYI N/A
- BRKH 2021
- Fundamental
- Price
- PBYI $2.25
- BRKH $11.28
- Analyst Decision
- PBYI Strong Buy
- BRKH
- Analyst Count
- PBYI 1
- BRKH 0
- Target Price
- PBYI $7.00
- BRKH N/A
- AVG Volume (30 Days)
- PBYI 393.7K
- BRKH 20.9K
- Earning Date
- PBYI 10-31-2024
- BRKH 01-01-0001
- Dividend Yield
- PBYI N/A
- BRKH N/A
- EPS Growth
- PBYI N/A
- BRKH N/A
- EPS
- PBYI 0.18
- BRKH N/A
- Revenue
- PBYI $219,143,000.00
- BRKH N/A
- Revenue This Year
- PBYI N/A
- BRKH N/A
- Revenue Next Year
- PBYI N/A
- BRKH N/A
- P/E Ratio
- PBYI $12.36
- BRKH N/A
- Revenue Growth
- PBYI N/A
- BRKH N/A
- 52 Week Low
- PBYI $2.13
- BRKH $10.47
- 52 Week High
- PBYI $7.73
- BRKH $11.28
- Technical
- Relative Strength Index (RSI)
- PBYI 31.78
- BRKH 75.39
- Support Level
- PBYI $2.42
- BRKH $11.12
- Resistance Level
- PBYI $2.56
- BRKH $11.24
- Average True Range (ATR)
- PBYI 0.17
- BRKH 0.01
- MACD
- PBYI -0.02
- BRKH 0.01
- Stochastic Oscillator
- PBYI 3.88
- BRKH 100.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BRKH BurTech Acquisition Corp.
BurTech Acquisition Corp is a blank check company.